Alex Grint, Bachelors

Clinical Trial Manager
TRACON Pharmaceuticals INC.

I have been in the Biotech Industry for over 7 years and have been with TRACON Pharmceuticals Inc. for 5 years. I started as a Clinical Trials Assitant and have worked my way up to my current role as a Clinical Trials Manager. Currently I am managing the YH001/KN035SAR101 Study.

Poster(s):

• (P 112) PHASE 1/2 STUDY OF YH001, A CTLA-4 ANTIBODY WITH THE SUBCUTANEOUSLY ADMINISTERED PD-L1 ANTIBODY ENVAFOLIMAB, WITH OR WITHOUT DOXORUBICIN IN PATIENTS WITH ADVANCED OR METASTATIC SOFT TISSUE SARCOMA